| Literature DB >> 27766891 |
Shakeela Yasmeen1, Sajjad Hussain Sumrra2, Muhammad Safwan Akram3, Zahid H Chohan4.
Abstract
A novel series of thiophene derivedEntities:
Keywords: Acetyl thiophene; antimicrobial activity; diammines; metal(II) chelates; tridentate ligands
Mesh:
Substances:
Year: 2016 PMID: 27766891 PMCID: PMC6009934 DOI: 10.1080/14756366.2016.1238363
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051
Scheme 1:Preparation of Schiff bases.
Scheme 2:Co(II), Ni(II), Cu(II) and Zn(II) metal complexes (1)–(12) with (L–(L.
Figure 1.Comparison of antibacterial activity of Schiff bases versus metal(II) complexes.
Physical measurements and analytical data of metal(II) complexes (1)–(12).
| Elemental analysis (%) Calc. (found) | ||||||||
|---|---|---|---|---|---|---|---|---|
| No. | Structure | Yield (%) | MW | M.P. (°C) | C | H | N | M |
| [Co(L1)2] | 75 | [466.36] C16H24N4S2Cl2Co | 311–312 | 41.21 (41.14) | 5.19 (5.16) | 12.01 (11.96) | 12.64 (12.60) | |
| [Ni(L1)2] | 72 | [466.12] C16H24N4S2Cl2Ni | 315–316 | 41.23 (41.17) | 5.19 (5.15) | 12.01 (11.97) | 12.59 (12.55) | |
| [Cu(L1)2] | 68 | [470.97] C16H24N4S2Cl2Cu | 300–301 | 40.80 (40.74) | 5.14 (5.11) | 11.90 (11.85) | 13.49 (13.44) | |
| [Zn(L1)2] | 65 | [472.81] C16H24N4S2Cl2Zn | 305–306 | 40.64 (40.58) | 5.12 (5.09) | 11.85 (11.81) | 13.56 (13.50) | |
| [Co(L2)2] | 69 | [494.41] C18H28N4S2Cl2Co | 309–311 | 43.73 (43.66) | 5.71 (5.68) | 11.33 (11.27) | 11.92 (11.88) | |
| [Ni(L2)2] | 70 | [494.17] C18H28N4S2Cl2Ni | 305–307 | 43.75 (43.70) | 5.71 (5.66) | 11.34 (11.30) | 11.88 (11.82) | |
| [Cu(L2)2] | 75 | [499.02] C18H28N4S2Cl2Cu | 321–322 | 43.32 (43.28) | 5.66 (5.63) | 11.23 (11.19) | 12.73 (12.68) | |
| [Zn(L2)2] | 72 | [500.87] C18H28N4S2Cl2Zn | 319–321 | 43.16 (43.08) | 5.63 (5.60) | 11.19 (11.15) | 12.80 (11.75) | |
| [Co(L3)2] | 78 | [522.46] C20H32N4S2Cl2Co | 305–306 | 45.98 (45.91) | 6.17 (6.13) | 10.72 (10.68) | 11.28 (11.23) | |
| [Ni(L3)2] | 68 | [522.22] C20H32N4S2Cl2Ni | 325–326 | 46.00 (46.94) | 6.18 (6.15) | 10.73 (10.68) | 11.24 (11.18) | |
| [Cu(L3)2] | 65 | [527.08] C20H32N4S2Cl2Cu | 329–331 | 45.57 (45.51) | 6.12 (6.08) | 10.63 (10.58) | 12.06 (12.02) | |
| [Zn(L3)2] | 71 | [528.92] C20H32N4S2Cl2Zn | 327–329 | 45.42 (45.35) | 6.10 (6.06) | 10.59 (10.55) | 12.36 (12.30) | |
Conductivity, magnetic and spectral data of metal(II) complexes (1)–(12).
| No. | ΩM (Ω−1 cm2 mol−1) | B.M. μeff | λm (cm−1) | IR (cm−1) |
|---|---|---|---|---|
| 88.3 | 4.2 | 7622, 17 490, 23 134, 29 858 | 3348 (NH2), 1663 (C=N), 1045 (C–N), 868 (C–S), 574 (M–N), 462 (M–S) | |
| 88.9 | 3.1 | 9875, 15 263, 25 743, 29 586 | 3350 (N–H), 1665 (C=N), 1044 (C–N), 870 (C–S), 565 (M–N), 460 (M–S) | |
| 92.7 | 2.2 | 15 713, 19 415, 29 967 | 3352 (NH2), 1666 (C=N), 1045 (C–N), 869 (C–S), 547 (M–N), 468 (M–S) | |
| 87.4 | Dia | 29 926 | 3355 (NH2),1668 (C=N), 1043 (C–N), 872 (C–S), 548 (M–N), 470 (M–S) | |
| 93.1 | 4.3 | 7590, 17 587, 23 252, 30 030 | 3330 (NH2),1645 (C=N), 1043 (C–N), 875 (C–S), 576 (M–N), 466 (M–S) | |
| 86.8 | 3.2 | 9939, 15 379, 25 865, 29 690 | 3336 (NH2),1642 (C=N), 1045 (C–N), 874 (C–S),561 (M–N), 465 (M–S) | |
| 92.3 | 2.4 | 15 681, 19 617, 29 935 | 3332 (NH2),1638 (C=N), 1044 (C–N), 873 (C–S), 573 (M–N), 463 (M–S) | |
| 87.0 | Dia | 29 898 | 3335 (NH2),1640 (C=N), 1045 (C–N), 871 (C–S), 546 (M–N), 470 (M–S) | |
| 91.2 | 4.5 | 7645, 17 642, 23 162, 29 961 | 3374 (NH2), 1649 (C=N), 1040 (C–N), 877 (C–S), 580 (M–N), 469 (M–S) | |
| 95.2 | 3.4 | 9914, 15 290, 25 812, 29 635 | 3375 (NH2), 1656 (C=N), 1041 (C–N), 876 (C–S), 568 (M–N), 463 (M–S) | |
| 90.5 | 2.5 | 15 802, 19 585, 29 892 | 3370 (NH2), 1652 (C=N), 1042 (C–N), 875 (C–S), 548 (M–N), 468 (M–S) | |
| 94.8 | Dia | 29 902 | 3372 (NH2), 1654 (C=N), 1043 (C–N), 874 (C–S), 543 (M–N), 471 (M–S) |
Antibacterial activity of ligands (L and metal(II) complexes (1)–(12).
| [Zone of inhibition (mm)] | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gram-negative | Gram-positive | |||||||
| Compounds | (a) | (b) | (c) | (d) | (e) | (f) | (SA) | Average |
| 10 | 13 | 12 | 16 | 10 | 16 | 2.71 | 12.83 | |
| 11 | 10 | 13 | 09 | 09 | 12 | 1.63 | 10.67 | |
| 13 | 16 | 15 | 19 | 08 | 09 | 3.66 | 13.33 | |
| 23 | 18 | 19 | 18 | 20 | 17 | 2.14 | 19.17 | |
| 20 | 21 | 11 | 18 | 19 | 21 | 3.78 | 18.33 | |
| 18 | 16 | 20 | 21 | 19 | 17 | 1.87 | 18.50 | |
| 19 | 21 | 18 | 23 | 17 | 16 | 2.61 | 19.00 | |
| 10 | 20 | 24 | 21 | 18 | 17 | 4.35 | 18.33 | |
| 19 | 20 | 24 | 17 | 23 | 16 | 3.19 | 19.83 | |
| 20 | 19 | 12 | 16 | 18 | 19 | 2.94 | 17.33 | |
| 12 | 16 | 20 | 21 | 24 | 18 | 4.18 | 18.50 | |
| 21 | 18 | 13 | 20 | 14 | 19 | 3.28 | 17.50 | |
| 16 | 21 | 18 | 17 | 25 | 19 | 3.27 | 19.33 | |
| 13 | 16 | 19 | 20 | 23 | 24 | 4.17 | 19.17 | |
| 18 | 24 | 17 | 20 | 21 | 17 | 2.74 | 19.50 | |
| SD | 25 | 26 | 25 | 26 | 27 | 28 | 1.07 | 26.17 |
Average activity of ligand (L = 12.28 mm; average activity of complexes (1)–(12) =18.71 mm; (a) E. coli, (b) P. aeruginosa, (c) S. typhi, (d) S. flexneri, (e) S. aureus and (f) B. subtilis; SD: standard drug (imipenem); weaker = 0–09 mm; moderate = 10–15 mm; above 16 mm = significant; SA: statistical analysis.
Antifungal activity of ligands (L–(L and metal(II) complexes (1)–(12).
| [% Inhibition (mm)] | ||||||||
|---|---|---|---|---|---|---|---|---|
| Compounds | (a) | (b) | (c) | (d) | (e) | (f) | (SA) | Average |
| 57 | 40 | 45 | 50 | 38 | 31 | 8.42 | 43.50 | |
| 41 | 60 | 39 | 00 | 56 | 38 | 19.39 | 39.00 | |
| 36 | 44 | 00 | 46 | 51 | 00 | 21.32 | 29.50 | |
| 74 | 62 | 67 | 62 | 60 | 56 | 5.71 | 63.50 | |
| 68 | 55 | 59 | 65 | 61 | 59 | 4.26 | 61.17 | |
| 71 | 59 | 56 | 71 | 59 | 58 | 6.21 | 62.33 | |
| 69 | 66 | 70 | 62 | 57 | 60 | 4.73 | 64.00 | |
| 60 | 75 | 61 | 29 | 69 | 57 | 14.51 | 58.50 | |
| 56 | 67 | 57 | 20 | 74 | 61 | 17.16 | 55.83 | |
| 65 | 76 | 60 | 31 | 61 | 55 | 13.69 | 58.00 | |
| 68 | 72 | 58 | 29 | 70 | 62 | 14.58 | 59.83 | |
| 59 | 57 | 42 | 70 | 78 | 27 | 16.95 | 55.50 | |
| 55 | 60 | 35 | 71 | 71 | 17 | 19.61 | 51.50 | |
| 66 | 64 | 40 | 60 | 62 | 31 | 13.35 | 53.83 | |
| 60 | 58 | 38 | 58 | 69 | 30 | 13.57 | 52.17 | |
| SD | A | B | C | D | E | F | – | – |
Average activity of ligands (L–(L = 37.33%; average activity of complexes (1)–(12) = 58.01%; (a) T. longifusus, (b) = C. albicans, (c) = A. flavus, (d) = M. canis, (e) = F. solani and (f) = C. glabrata; SD: standard drugs; MIC μg/mL; A = miconazole (70 μg/mL: 1.6822 × 10−7 M/mL), B = miconazole (110.8 μg/mL: 2.6626 × 10−7 M/mL), C = amphotericin B (20 μg/mL:2.1642 × 10−8 M/mL), D = miconazole (98.4 μg/mL: 2.3647 × 10−7 M/mL), E = miconazole (73.25 μg/mL: 1.7603 × 10−7 M/mL) and F = miconazole (110.8 μg/mL: 2.66 266 × 10−7 M/mL); weaker = 0–33%; moderate = 34–54%; 55–100% = significant; SA: statistical analysis.
Figure 2.Comparison of antifungal activity of Schiff bases versus metal(II) complexes.
Minimum inhibitory concentration (μg/mL) of the metal complexes (1)–(12).
| Compounds | ||||||
|---|---|---|---|---|---|---|
| 18.42 | – | – | – | – | – | |
| 23.69 | – | – | – | – | – | |
| – | – | 33.93 | 24.32 | – | – | |
| – | 38.86 | – | 19.23 | – | – | |
| – | – | 36.61 | – | – | – | |
| – | – | 30.08 | – | 19.55 | – | |
| 38.22 | – | – | – | – | – | |
| – | – | 26.43 | 39.91 | 22.39 | – | |
| 31.52 | – | – | – | – | – | |
| – | 33.35 | – | – | 32.36 | – | |
| – | – | – | – | 26.31 | 19.42 | |
| – | 36.73 | – | – | – | – |